Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
US |
|
Sherwin-Williams Co
NYSE:SHW
|
US |
|
Cass Information Systems Inc
NASDAQ:CASS
|
US |
|
F
|
Forwardly Inc
OTC:FORW
|
US |
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
Intellicheck Inc
NASDAQ:IDN
|
US |
|
Orkla ASA
OTC:ORKLF
|
NO |
Shareholder Yield
Current shareholder yield for ARWR is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ARWR Price
Arrowhead Pharmaceuticals Inc
| Average Annual Return | 30.45% |
| Standard Deviation of Annual Returns | 125.54% |
| Max Drawdown | -88% |
| Market Capitalization | 9.6B USD |
| Shares Outstanding | 140 860 000 |
| Percentage of Shares Shorted | 11.61% |
ARWR Return Decomposition
Main factors of price return
Stock Splits
ARWR's latest stock split occurred on Nov 17, 2011
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, ARWR traded at 0.645 per share. Afterward, the share price was about 6.03.
The adjusted shares began trading on Nov 17, 2011. This was stock split number 2 in ARWR's history, following the previous one in Jan 15, 2004.